Updated Covid Vaccines: Staying Ahead of the Variant Curve
Year: 2025
Type: article
Abstract: This article explores the 2024–2025 coronavirus disease-2019 (COVID-19) vaccines targeting new variants, including KP. 2, KP. 3, and JN.1. As breakthrough infections increase, these updated vaccines aim to restore waning immunity, particularly in high-risk groups. We assess the evolution of key variants like delta and omicron, their impact on immune evasion, and the effectiveness of bivalent and monovalent vaccines. Future strategies may include mucosal vaccines and annual boosters tailored to circulating variants, emphasizing the need for ongoing research and monitoring to enhance community protection against COVID-19.
Authors: Vasantha Kamath, B. Nivea
Institution: MVJ Medical College and Research Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4408919786